Research

Latest

Denali Announce Positive LRRK2 Trial Results with Advance to Phase 1b Trial

Denali Therapeutics has announced positive clinical results from their LRRK2 inhibitor programme and their advance to a Phase 1b trial in Parkinson’s patients with and without a genetic LRRK2 mutation.
The Wobbly Walkers take on the Wye Valley Challenge

Over the weekend of the 11th and 12th August CPT supporter Patrick Farrelly along with his youngest son Angus took on the Wye Valley Challenge to raise awareness and funds for CPT’s research into a cure for Parkinson’s.
Cure3 2018: Art for Parkinson's

We are delighted that Cure3 is taking place again this year! Over 80 leading artists and architects will create exclusive works which will be sold at this unique selling exhibition...
Cure3 Art Exhibition

From the 26th to the 28th October the Cure3 Exhibition will be open to the public: a unique selling exhibition featuring original works by more than 80 leading international artists, taking place at Bonhams, London in association with Artwise and in support of The Cure Parkinson's Trust

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Science news

Read the latest Parkinson's science and research news here.
Our story
The NAC Trial - the facts
Apply for Funding
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Stem Cell Therapies - Research Update

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.

Science news

Read the latest Parkinson's science and research news here. Read more

The Annual Review 2018

Our Annual Review 2018 - your online publication here... Read more

Alison Anderson - Fundraiser of the Year 2017

We are delighted that Alison Anderson is the Alex Flynn Award winner of 2017! Following her diagnosis with Parkinson's, Alison was determined to move forward with optimism - so she took on an awesome and inspiring challenge... Read more

Leave a gift in your Will

A donation to The Cure Parkinson's Trust will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more